President Donald Trump arrived Friday evening at Walter Reed National Military Medical Center, where the White House says he will remain hospitalized for “the next few days.”
Emerging from the White House residence at 6:16 p.m. ET for his first public appearance since announcing 16 hours earlier he had tested positive for coronavirus, Trump walked under his own power to his waiting helicopter and displayed no major outward signs of illness.
Wearing a navy blue suit, a blue silk necktie and a dark face mask, Trump waved to the media and gave a thumbs up, but did not stop to talk. Chief of staff Mark Meadows, also wearing a mask, followed him aboard.
President Donald Trump has received an experimental drug following his diagnosis of Covid-19, the White House said Friday.
“As a precautionary measure, he received a single 8 gram dose of Regeneron’s polyclonal antibody cocktail. He completed the infusion without incident,” Dr. Sean Conley, the president’s physician, wrote in a memorandum.
The drug cocktail is a combination of two so-called monoclonal antibodies. The treatment is meant to provide the body’s immune system with a temporary, but immediate, boost to fight off the coronavirus.
Monoclonal antibodies (or, in this case, polyclonal because there are two in the cocktail) are made in a lab to mimic the body’s natural antibodies. Antibodies act by recognizing specific germs — in this case, SARS-CoV-2, the virus that causes Covid-19 — and harnessing the immune system to fight them off.
The therapy, though still unproven, is considered by experts to be one of the most promising treatment options for the illness.Regeneron confirmed it provided its drug to the president under what is called “compassionate use,” through which the Food and Drug Administration allows access to experimental drugs outside of clinical trials for patients with a life-threatening condition or serious disease.